Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRMT3 | O60678 | 7/20 | 0.55 |
| ▸ | IMPDH2 | P12268 | 2/20 | 0.46 |
| ▸ | NAMPT | P43490 | 5/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | ROCK2 | O75116 | 3/20 | 0.41 |
| ▸ | ROCK1 | Q13464 | 2/20 | 0.41 |
| ▸ | F3 | P13726 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31037302 | 0.90 | NAMPT (0.51) | PRMT3NAMPTLMNAROCK2ROCK1 | |
| SCHEMBL31037468 | 0.86 | LMNA (0.44) | PRMT3NAMPTLMNAROCK2ROCK1 | |
| SCHEMBL31037290 | 0.83 | NAMPT (0.40) | PRMT3NAMPTLMNAROCK2ROCK1 | |
| SCHEMBL31037286 | 0.82 | LMNA (0.48) | PRMT3NAMPTLMNA | |
| SCHEMBL31037293 | 0.82 | LMNA (0.48) | PRMT3NAMPTLMNA | |
| SCHEMBL31037336 | 0.82 | NAMPT (0.42) | PRMT3NAMPTLMNAROCK2 | |
| SCHEMBL31037281 | 0.82 | ROCK2 (0.48) | PRMT3NAMPTLMNAROCK2ROCK1 | |
| SCHEMBL31037447 | 0.81 | ROCK2 (0.49) | PRMT3NAMPTROCK2ROCK1 | |
| SCHEMBL31037269 | 0.80 | ROCK2 (0.46) | PRMT3NAMPTROCK2ROCK1 | |
| SCHEMBL31037371 | 0.79 | NAMPT (0.48) | PRMT3NAMPTROCK2ROCK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4663628-A1 | NEW COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | Samjin Pharmaceutical Co., Ltd. (KR) | 2025-12-17 | — | — | EP | disclosed |
| WO-2024166024-A1 | NEW COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | 삼진제약주식회사 | 2024-08-15 | — | — | WO | disclosed |